KRAS and non-small cell lung carcinoma: Our results suggest that knockdown of Kras reduces cell proliferation in vitro and decreases tumorigenesis in vivo which are in consistent with previous reports in the NSCLC cell lines [28] and pancreatic cancer cell line CAPAN-1 both harboring oncogene Kras [29].